Your browser is no longer supported. Please, upgrade your browser.
Settings
HOLX Hologic, Inc. daily Stock Chart
HOLX [NASD]
Hologic, Inc.
IndexS&P 500 P/E- EPS (ttm)-0.11 Insider Own0.20% Shs Outstand269.24M Perf Week1.13%
Market Cap13.00B Forward P/E18.37 EPS next Y2.63 Insider Trans-4.93% Shs Float267.27M Perf Month7.64%
Income-24.80M PEG- EPS next Q0.61 Inst Own99.00% Short Float2.28% Perf Quarter1.83%
Sales3.29B P/S3.96 EPS this Y-162.90% Inst Trans-0.53% Short Ratio4.39 Perf Half Y15.16%
Book/sh8.02 P/B6.02 EPS next Y8.59% ROA-0.20% Target Price48.33 Perf Year19.47%
Cash/sh1.49 P/C32.43 EPS next 5Y8.87% ROE-0.40% 52W Range37.47 - 48.82 Perf YTD17.52%
Dividend- P/FCF19.75 EPS past 5Y17.60% ROI-5.60% 52W High-0.78% Beta0.72
Dividend %- Quick Ratio1.00 Sales past 5Y5.20% Gross Margin52.00% 52W Low29.28% ATR0.79
Employees6252 Current Ratio1.40 Sales Q/Q3.70% Oper. Margin1.50% RSI (14)72.66 Volatility1.43% 1.63%
OptionableYes Debt/Eq1.45 EPS Q/Q58.70% Profit Margin-0.30% Rel Volume0.29 Prev Close48.30
ShortableYes LT Debt/Eq1.31 EarningsMay 01 AMC Payout- Avg Volume1.39M Price48.44
Recom2.40 SMA205.39% SMA505.89% SMA20011.36% Volume100,194 Change0.29%
May-02-19Reiterated Needham Buy $50 → $52
Jan-31-19Reiterated Needham Buy $48 → $50
Jan-02-19Downgrade Morgan Stanley Equal-Weight → Underweight
Oct-09-18Initiated UBS Neutral
Sep-13-18Downgrade BofA/Merrill Buy → Neutral
Aug-01-18Reiterated Needham Buy $43 → $48
May-03-18Reiterated Needham Buy $50 → $43
May-03-18Downgrade Leerink Partners Outperform → Mkt Perform
May-03-18Downgrade Canaccord Genuity Buy → Hold $48 → $39
Feb-09-18Downgrade Stifel Buy → Hold $45 → $42
Jan-09-18Reiterated Needham Buy $48 → $50
Jan-04-18Upgrade BofA/Merrill Neutral → Buy
Jan-03-18Initiated Evercore ISI Outperform
Dec-05-17Reiterated Needham Buy $46 → $48
Oct-09-17Reiterated Stifel Buy $48 → $45
Aug-03-17Reiterated RBC Capital Mkts Sector Perform $50 → $45
May-11-17Reiterated Stifel Buy $45 → $48
Apr-04-17Reiterated Needham Buy $46 → $50
Mar-30-17Resumed Leerink Partners Outperform
Feb-15-17Upgrade Needham Hold → Buy $46
Jun-13-19 07:36PM  Is Hologic, Inc. (HOLX) A Good Stock To Buy? Insider Monkey
09:30AM  HOLX or EW: Which Is the Better Value Stock Right Now? Zacks
08:08AM  Hologic Receives Manufacturing Leadership Awards for Operational Excellence and Sustainability Business Wire
Jun-07-19 11:52AM  A Look At The Fair Value Of Hologic, Inc. (NASDAQ:HOLX) Simply Wall St.
May-31-19 09:31AM  Hologic (HOLX) Down 5.2% Since Last Earnings Report: Can It Rebound? Zacks
May-30-19 08:30AM  Hologic Partners with DEXA+ to Distribute Body Composition Measurement System Business Wire
May-29-19 08:08AM  FDA Clearance of Aptima BV and Aptima CV/TV Molecular Assays Ushers in New Era of Comprehensive and Objective Diagnostic Testing for Vaginitis Business Wire
May-28-19 08:15AM  Hologic to Webcast Presentations at Upcoming Investor Conferences Business Wire
May-22-19 11:16AM  Hologic Breast Health Arm Aids Strongly, Rising Costs Ail Zacks
May-20-19 09:30AM  HOLX vs. EW: Which Stock Is the Better Value Option? Zacks
May-08-19 05:15PM  Kahn Brothers Trims New York Times, Hologic Positions GuruFocus.com
May-07-19 08:20AM  Hologic to Webcast Presentations at Upcoming Investor Conferences Business Wire
May-03-19 03:40AM  Edited Transcript of HOLX earnings conference call or presentation 1-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-02-19 07:56PM  Cramer Remix: Why buybacks have not benefited Bed Bath & Beyond CNBC
07:17PM  Hologic CEO: Preventing false positives with 3D mammography technology CNBC
08:45AM  Hologic's (HOLX) Q2 Earnings Beat Estimates, Margins Fall Zacks
08:12AM  Hologic Showcases Growing Portfolio of Womens Health Products at 2019 American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting Business Wire
May-01-19 10:33PM  Hologic Inc (HOLX) Q2 2019 Earnings Call Transcript Motley Fool
05:15PM  Hologic (HOLX) Beats Q2 Earnings and Revenue Estimates Zacks
04:11PM  Hologic: Fiscal 2Q Earnings Snapshot Associated Press
04:02PM  Hologic Announces Financial Results for Second Quarter of Fiscal 2019 Business Wire
11:48AM  Hologic's Q2 Earnings Preview Benzinga
Apr-30-19 08:10AM  Hologic Showcases New Breast Surgery Franchise at 20th Annual Meeting of The American Society of Breast Surgeons Business Wire
Apr-25-19 08:15AM  Hologic Launches Trident® HD Specimen Radiography System in United States, Canada and Europe Business Wire
Apr-24-19 10:33AM  Hologic (HOLX) Earnings Expected to Grow: Should You Buy? Zacks
Apr-23-19 08:30AM  Hologics Cynosure Division Announces Brooke Shields as Celebrity Spokesperson for SculpSure® Body Contouring Business Wire
Apr-17-19 02:03PM  How Financially Strong Is Hologic, Inc. (NASDAQ:HOLX)? Simply Wall St. -5.15%
10:14AM  Double Top Spells Trouble for 3 Health Care Stocks Investopedia
Apr-16-19 10:49AM  Hologic's Diagnostics Grows Strong, Escalating Costs a Woe Zacks
Apr-04-19 04:31PM  Were Hedge Funds Right About Flocking Into Hologic, Inc. (HOLX)? Insider Monkey
Apr-03-19 08:12AM  Hologic to Announce Financial Results for the Second Quarter of Fiscal 2019 on Wednesday, May 1, 2019 Business Wire
Apr-01-19 09:10AM  Here's Why You Should Invest in ResMed (RMD) Stock Right Now Zacks
09:09AM  Genomic Health's New Positive Data to Boost Test Uptake Zacks
Mar-29-19 08:30AM  Hologic Applauds FDAs Proposed Rule to Update Mammography Regulations Issued Under the Mammography Quality Standards Act (MQSA) of 1992 Business Wire
Mar-28-19 11:02AM  Here's Why You Should Buy IDEXX Laboratories (IDXX) Stock Zacks
Mar-27-19 07:59AM  Neogen (NEOG) Earnings and Revenues Miss Estimates in Q3 Zacks
Mar-26-19 10:17AM  Zimmer Biomet's FDA 510(k) Nod Widens Robotic Offerings Zacks
Mar-25-19 10:55AM  Here's Why You Should Invest in Genomic Health (GHDX) Now Zacks
10:54AM  Abbott's New CE Mark to Boost Core Laboratory Diagnostics Arm Zacks
Mar-22-19 11:39AM  National Vision (EYE) Rides on Positive Comps Amid Cost Woes Zacks
11:18AM  STERIS (STE) Margin Pressure Hurts, Strategic Growth High Zacks
11:15AM  TeleFlex Announces Multiple Positive Outcomes on UroLift Zacks
Mar-21-19 06:00AM  Hologic Opens State-Of-The-Art Learning and Experience Centre In Zaventem, Belgium Business Wire
Mar-20-19 10:34AM  Abbott (ABT) Gains Ground on Solid EPD and Diabetes Arms Zacks
Mar-19-19 03:55PM  Phibro Animal Solid on Global Prospects, Currency Woes Ail Zacks
10:42AM  Henry Schein's New Buyout to Boost Dental Technology Business Zacks
Mar-18-19 09:04AM  Zimmer Biomet Solid on Global Prospects Despite Price Pressure Zacks
09:03AM  Myriad's myPath Melanoma Test Awarded Medicare Coverage Zacks
Mar-15-19 09:01AM  Align Technology (ALGN) Partners With Digital Smile Design Zacks
Mar-14-19 09:43AM  Boston Scientific's WATCHMAN FLX LAAC Device Gets CE Mark Zacks
Mar-13-19 08:33AM  HOLX vs VAR: Which MedTech Stock is a Better Investment Pick? Zacks
Mar-12-19 09:02AM  QIAGEN Partners With Tecan to Advance QFT-Plus Diagnostic Test Zacks
08:47AM  Here's Why You Should Add Amedisys (AMED) to Your Portfolio Zacks
Mar-11-19 09:15AM  Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio Zacks
08:48AM  HOLX vs DXCM: Which MedTech Stock is a Better Investment Pick? Zacks
Mar-08-19 02:04PM  Shareholders Are Thrilled That The Hologic (NASDAQ:HOLX) Share Price Increased 118% Simply Wall St.
Mar-05-19 07:46AM  Here's Why You Must Add Hologic (HOLX) to Your Portfolio Now Zacks
07:42AM  Hologic (HOLX) Receives Global Nods for Omni Hysteroscope Zacks
07:30AM  New Research: Key Drivers of Growth for Marsh & McLennan Companies, Conagra Brands, Amgen, Emerson Electric, Polaris Industries, and Hologic Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Mar-04-19 04:01PM  Hologic to Webcast Presentations at Upcoming Investor Conferences Business Wire
08:00AM  Hologic Receives CE Mark for Three-in-One Omni Hysteroscope in Europe Business Wire
Feb-27-19 03:13PM  Hologic, Inc. -- Moody's changes outlook on Hologic's ratings to positive, affirms Ba2 CFR Moody's
Feb-19-19 12:57PM  Dianne Feinsteins Husband, Richard Blum, Bought Nvidia, FedEx Stock, Sold 3M Stock Barrons.com
Feb-14-19 03:00AM  Hologics Aptima HIV-1 Quant Dx Assay Receives Two CE Marks, Making It the First and Only Dual-Claim Assay for Both Viral Load and Early Infant Diagnosis Business Wire
Feb-07-19 04:43PM  Bright Near-Term Outlook for Medical Instruments Industry Zacks
Feb-04-19 10:00AM  Here's Why Momentum Investors Will Love Hologic (HOLX) Zacks
Jan-31-19 09:13PM  Edited Transcript of HOLX earnings conference call or presentation 30-Jan-19 9:30pm GMT Thomson Reuters StreetEvents
12:05PM  Hologic's (HOLX) Q1 Earnings Beat Estimates, Guidance Raised Zacks
09:01AM  The Daily Biotech Pulse: Hologic, Celgene Earnings, FDA To Rule On Alkermes Depression Drug Benzinga
Jan-30-19 10:51PM  Hologic Inc (HOLX) Q1 2019 Earnings Conference Call Transcript Motley Fool
05:40PM  Hologic (HOLX) Q1 Earnings and Revenues Beat Estimates Zacks
04:31PM  Hologic: Fiscal 1Q Earnings Snapshot Associated Press
04:01PM  Hologic Announces Financial Results for First Quarter of Fiscal 2019 Business Wire
Jan-24-19 10:19AM  What's Setting the Tone for Hologic's (HOLX) Q1 Earnings? Zacks
Jan-23-19 05:48PM  New Hologic Assay is First and Only FDA-Cleared Diagnostic Test to Detect Emerging Health Threat Mycoplasma genitalium Business Wire
04:02PM  These stocks historically jump the most during the first earnings season of the year CNBC
10:30AM  Hologic (HOLX) Earnings Expected to Grow: Should You Buy? Zacks
Jan-17-19 07:25AM  Market Trends Toward New Normal in Altria Group, Anthem, SemGroup, Axcelis Technologies, M.D.C., and Hologic Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jan-16-19 01:55PM  Hologic, Inc.s (NASDAQ:HOLX) Investment Returns Are Lagging Its Industry Simply Wall St.
Jan-11-19 07:29AM  3 Big Stock Charts for Friday: General Electric, Hologic and MGM Resorts InvestorPlace
Jan-08-19 09:42AM  Hologic Stock Rides on Impressive Preliminary Q1 Result Zacks
Jan-07-19 09:00AM  Hologic to Announce Financial Results for the First Quarter of Fiscal 2019 on Wednesday, January 30, 2019 Business Wire
08:14AM  Hologic's stock surges after revenue outlook beats expectations MarketWatch
08:00AM  Hologic Preliminary Revenues Increase Approximately 5% to $831 Million in First Quarter of Fiscal 2019 Business Wire
Jan-06-19 09:27AM  Benzinga's Bulls & Bears Of The Week: Amazon, CBS, Intel, Nike, Tesla And More Benzinga
Jan-03-19 02:37PM  Analysts Issue New Ratings on Large Health Care Stocks GuruFocus.com
Jan-02-19 05:13PM  Dow Gains 19 Points Because a New Year Starts With a Clean Slate Barrons.com -6.52%
04:35PM  Why Tesla, MyoKardia, and Hologic Slumped Today Motley Fool
01:14PM  Hologic shares slide 5% after Morgan Stanley downgrade MarketWatch
11:01AM  Morgan Stanley Downgrades Hologic On Tough Cynosure Recovery, Surgery Business Risks Benzinga
Dec-19-18 08:15AM  Hologic to Webcast Presentation at the 37th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-14-18 07:47AM  The Daily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch Benzinga
06:41AM  Hologic's (HOLX) New Offering to Revitalize Cynosure Division Zacks
Dec-13-18 11:30PM  Is Hologic, Inc. (HOLX) A Good Stock To Buy? Insider Monkey
04:05PM  Hologics Cynosure Division Launches TempSure Surgical RF Technology in North America Business Wire
Dec-12-18 08:10AM  Massachusetts Superior Court Grants Hologic Preliminary Injunction in Trade Secrets Lawsuits Business Wire
07:30AM  Report: Developing Opportunities within Exelixis, Cintas, BGC Partners, FirstEnergy, Hologic, and Trevena Future Expectations, Projections Moving into 2018 GlobeNewswire
Dec-11-18 01:31PM  Heres What We Think About Hologic, Inc.s (NASDAQ:HOLX) CEO Pay Simply Wall St.
09:46AM  Hologic Unveils Omni Hysteroscope, Boosts GYN Surgical Arm Zacks
Dec-10-18 08:07AM  Hologic Launches Three-in-One Omni Hysteroscope Business Wire
Hologic, Inc., a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. It operates in five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health. The company offers Aptima molecular diagnostic assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assay technologies, instrumentation, Invader chemistry platform, ThinPrep system, and rapid fetal fibronectin test products. It also provides breast imaging and analytics products, such as 2D and 3D mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, and breast biopsy and biopsy site markers, as well as localization, specimen radiology, ultrasound, and connectivity solutions. In addition, the company offers Selenia Dimensions and 3Dimensions gantries for performing 2D and tomosynthesis image acquisition and display; C-View and Intelligent 2D software products; SecurView Workstations; computer aided detection systems; and stereotactic breast biopsy systems. Further, it provides SculpSure, PicoSure, and MonaLisa Touch aesthetic treatment systems; TempSure, a radio frequency energy sourced platform; and MedLite and other products, and system components for medical aesthetics. Additionally, the company offers NovaSure, an endometrial ablation system to treat women suffering from abnormal uterine bleeding; MyoSure surgical products for removal of fibroids, and uterine polyps and other pathology; and Horizon DXA System and Fluoroscan Insight FD skeletal health products. It sells its products through direct sales and service forces, and a network of independent distributors and sales representatives. The company was founded in 1985 and is headquartered in Marlborough, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Valenti Peter J. IIIDivision Pres., Breast HealthJun 03Sale44.074,545200,29850,353Jun 05 04:15 PM
CRAWFORD SALLYDirectorMar 18Option Exercise20.0112,306246,243168,886Mar 20 04:09 PM
CRAWFORD SALLYDirectorMar 18Sale47.6112,306585,889156,580Mar 20 04:09 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerMar 11Option Exercise19.866,830135,64422,002Mar 13 04:18 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerMar 11Sale46.706,830318,96115,172Mar 13 04:18 PM
Valenti Peter J. IIIDivision Pres., Breast HealthMar 01Sale47.384,242200,98654,898Mar 05 08:02 PM
Valenti Peter J. IIIDivision Pres., Breast HealthDec 07Sale42.204,740200,02859,140Dec 11 04:20 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 30Option Exercise19.8610,000198,60025,495Dec 04 04:21 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 30Sale44.4910,000444,87015,495Dec 04 04:21 PM
Stamoulis ChristianaDirectorNov 28Option Exercise17.5113,257232,13048,296Nov 30 04:19 PM
Stamoulis ChristianaDirectorNov 28Sale44.5013,257589,95035,039Nov 30 04:19 PM
Bebo Allison PSVP, Human ResourcesNov 16Sale42.006,500273,00024,736Nov 20 04:12 PM
Oberton Karleen MarieChief Financial OfficerNov 08Sale41.901,31254,97310,206Nov 09 04:10 PM
Oberton Karleen MarieChief Financial OfficerNov 07Sale40.833,806155,39910,206Nov 09 04:10 PM
Oberton Karleen MarieChief Financial OfficerNov 06Sale39.9654621,81815,601Nov 07 05:03 PM
Stamoulis ChristianaDirectorOct 02Option Exercise15.2930,967473,48566,006Oct 04 04:39 PM
Stamoulis ChristianaDirectorOct 02Sale40.7030,9671,260,48135,039Oct 04 04:39 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerSep 19Option Exercise17.093,43758,73816,520Sep 21 04:18 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerSep 19Sale41.503,437142,63613,083Sep 21 04:18 PM
CRAWFORD SALLYDirectorSep 17Option Exercise17.5113,257232,130167,701Sep 19 04:55 PM
CRAWFORD SALLYDirectorSep 17Sale39.5413,257524,169154,444Sep 19 04:55 PM